株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の個別化医療市場規模、シェア、動向分析:製品別(個別化医療ケア、治療薬、個別化栄養・ウェルネス)、地域別、セグメント予測(2019~2025年)

Personalized Medicine Market Size, Share & Trends Analysis By Product (Personalized Medical Care, Therapeutics, Personalized Nutrition & Wellness), By Region (Asia Pacific, Europe, North America), And Segment Forecasts, 2019 - 2025

発行 Grand View Research, Inc. 商品コード 603176
出版日 ページ情報 英文 128 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
世界の個別化医療市場規模、シェア、動向分析:製品別(個別化医療ケア、治療薬、個別化栄養・ウェルネス)、地域別、セグメント予測(2019~2025年) Personalized Medicine Market Size, Share & Trends Analysis By Product (Personalized Medical Care, Therapeutics, Personalized Nutrition & Wellness), By Region (Asia Pacific, Europe, North America), And Segment Forecasts, 2019 - 2025
出版日: 2019年06月19日 ページ情報: 英文 128 Pages
概要

世界の個別化医療市場規模は今後CAGR10.6%で拡大し、2025年までに3兆1,800億米ドルに達すると予測されています。認可されたコンパニオン診断薬やバイオマーカー製品の増加が、最新の精密診断検査の開発を促しています。

当レポートでは、世界の個別化医療市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 調査方法

第2章 エグゼクティブサマリー

第3章 市場変動、動向、範囲

  • 市場見通し
  • 浸透および成長見通しマッピング
  • 製品パイプライン分析
  • コスト構造分析
  • ユーザー見通し分析
  • 主なエンドユーザーリスト
  • 技術概要
  • 法規制の枠組み
  • 市場動向
  • 市場分析ツール

第4章 競合分析

  • 近年の発展と影響分析
  • 企業/競合分類
  • ベンダー動向
  • 公的企業
  • 民間企業

第5章 製品別予測と動向分析

  • 定義と範囲
  • 市場シェア
  • 動向分析
  • 世界市場
  • 市場規模と予測、動向分析
    • 診断薬
    • 治療薬
    • メディカルケア
    • 栄養・ウェルネス

第6章 地域別予測と動向

  • 市場シェア
  • 地域別市場シェアと主要企業
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第7章 競合環境

  • 企業リスト
  • 戦略枠組み
  • 市場参入分類
  • 企業プロファイル
図表

List of Tables

  • TABLE 1 Global cancer incidences, 2012
  • TABLE 2 North America cancer incidences in 2012
  • TABLE 3 Europe cancer incidences, 2012
  • TABLE 4 Asia cancer incidences, 2012
  • TABLE 5 Africa cancer incidences, 2012
  • TABLE 6 Australia and New Zealand cancer incidences in 2012
  • TABLE 7 Healthcare expenditure levels, 2012
  • TABLE 8 North America personalized medicine market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 9 North America PM diagnostics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 10 North America PM therapeutics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 11 North America personalized medical care market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 12 North America personalized nutrition & wellness market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 13 U.S. personalized medicine market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 14 U.S. PM diagnostics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 15 U.S. PM therapeutics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 16 U.S. personalized medical care market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 17 U.S. personalized nutrition & wellness market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 18 Canada personalized medicine market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 19 Canada PM diagnostics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 20 Canada PM therapeutics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 21 Canada personalized medical care market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 22 Canada personalized nutrition & wellness market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 23 Europe personalized medicine market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 24 Europe PM diagnostics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 25 Europe PM therapeutics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 26 Europe personalized medical care market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 27 Europe personalized nutrition & wellness market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 28 Germany personalized medicine market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 29 Germany PM diagnostics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 30 Germany PM therapeutics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 31 Germany personalized medical care market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 32 Germany personalized nutrition & wellness market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 33 U.K. personalized medicine market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 34 U.K. PM diagnostics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 35 U.K. PM therapeutics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 36 U.K. personalized medical care market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 37 U.K. personalized nutrition & wellness market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 38 Asia Pacific personalized medicine market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 39 Asia Pacific PM diagnostics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 40 Asia Pacific PM therapeutics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 41 Asia Pacific personalized medical care market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 42 Asia Pacific personalized nutrition & wellness market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 43 Japan personalized medicine market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 44 Japan PM diagnostics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 45 Japan PM therapeutics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 46 Japan personalized medical care market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 47 Japan personalized nutrition & wellness market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 48 China personalized medicine market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 49 China PM diagnostics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 50 China PM therapeutics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 51 China personalized medical care market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 52 China personalized nutrition & wellness market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 53 Latin America personalized medicine market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 54 Latin America PM diagnostics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 55 Latin America PM therapeutics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 56 Latin America personalized medical care market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 57 Latin America personalized nutrition & wellness market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 58 Brazil personalized medicine market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 59 Brazil PM diagnostics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 60 Brazil PM therapeutics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 61 Brazil personalized medical care market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 62 Brazil personalized nutrition & wellness market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 63 MEA personalized medicine market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 64 MEA PM diagnostics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 65 MEA PM therapeutics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 66 MEA personalized medical care market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 67 MEA personalized nutrition & wellness market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 68 South Africa personalized medicine market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 69 South Africa PM diagnostics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 70 South Africa PM therapeutics market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 71 South Africa personalized medical care market estimates & forecasts, by product, 2014 - 2025 (USD Billion)
  • TABLE 72 South Africa personalized nutrition & wellness market estimates & forecasts, by product, 2014 - 2025 (USD Billion)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain based sizing & forecasting
  • FIG. 6 QFD modelling for market share assessment
  • FIG. 7 Market summary
  • FIG. 8 Market trends & outlook
  • FIG. 9 Market segmentation & scope
  • FIG. 10 Market driver relevance analysis (Current & future impact)
  • FIG. 11 Estimated new cancer cases and related mortality in the U.S, 2015 - 2017
  • FIG. 12 Estimated new cancers, female, 2016
  • FIG. 13 Estimated new cancers, male, 2016
  • FIG. 14 Market restraint relevance analysis (Current & future impact)
  • FIG. 15 Penetration & growth prospect mapping for PM Medical Care & PM Nutrition, 2018
  • FIG. 16 Penetration & growth prospect mapping for PM Medical Care & PM Nutrition, 2018
  • FIG. 17 SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 18 Porter's Five Forces Analysis
  • FIG. 19 Personalized medicine - application opportunity v/s implementation, 2014 - 2025
  • FIG. 20 Personalized medicine - Application opportunities prioritized, 2014 - 2025
  • FIG. 21 Global personalized medicine market: Product outlook key takeaways
  • FIG. 22 Global personalized medicine market: Product movement analysis
  • FIG. 23 Global PM diagnostics market, 2014 - 2025 (USD Billion)
  • FIG. 24 Global genetic testing market, 2014 - 2025 (USD Billion)
  • FIG. 25 Global DTC diagnostics market, 2014 - 2025 (USD Billion)
  • FIG. 26 Global esoteric lab services market, 2014 - 2025 (USD Billion)
  • FIG. 27 Global esoteric lab tests market, 2014 - 2025 (USD Billion)
  • FIG. 28 Global PM therapeutics market, 2014 - 2025 (USD Billion)
  • FIG. 29 Global PM pharmaceuticals market, 2014 - 2025 (USD Billion)
  • FIG. 30 Global genomic medicine market, 2014 - 2025 (USD Billion)
  • FIG. 31 Global medical devices market, 2014 - 2025 (USD Billion)
  • FIG. 32 Global personalized medical care market, 2014 - 2025 (USD Billion)
  • FIG. 33 Global telemedicine market, 2014 - 2025 (USD Billion)
  • FIG. 34 Global health information technology market, 2014 - 2025 (USD Billion)
  • FIG. 35 Global disease management market, 2014 - 2025 (USD Billion)
  • FIG. 36 Global personalized nutrition & wellness market, 2014 - 2025 (USD Billion)
  • FIG. 37 Global retail nutrition market, 2014 - 2025 (USD Billion)
  • FIG. 38 Global complementary medicine market, 2014 - 2025 (USD Billion)
  • FIG. 39 Global alternative medicine market, 2014 - 2025 (USD Billion)
  • FIG. 40 Regional market place: Key takeaway
  • FIG. 41 Personalized medicine regional outlook, 2018 & 2025
  • FIG. 42 North America personalized medicine market, 2014 - 2025 (USD Billion)
  • FIG. 43 U.S. personalized medicine market, 2014 - 2025 (USD Billion)
  • FIG. 44 Canada personalized medicine market, 2014 - 2025 (USD Billion)
  • FIG. 45 Europe personalized medicine market, 2014 - 2025 (USD Billion)
  • FIG. 46 Germany personalized medicine market, 2014 - 2025 (USD Billion)
  • FIG. 47 U.K. personalized medicine market, 2014 - 2025 (USD Billion)
  • FIG. 48 Asia Pacific personalized medicine market, 2014 - 2025 (USD Billion)
  • FIG. 49 Japan personalized medicine market, 2014 - 2025 (USD Billion)
  • FIG. 50 China personalized medicine market, 2014 - 2025 (USD Billion)
  • FIG. 51 Latin America personalized medicine market, 2014-2025 (USD Billion)
  • FIG. 52 Brazil personalized medicine market, 2014 - 2025 (USD Billion)
  • FIG. 53 Middle East & Africa personalized medicine market, 2014 - 2025 (USD Billion)
  • FIG. 54 South Africa personalized medicine market, 2014 - 2025 (USD Billion)
  • FIG. 55 List of companies
  • FIG. 56 Strategy framework
  • FIG. 57 Participant categorization
目次
Product Code: 978-1-68038-443-7

The global personalized medicine (PM) market size is expected to reach USD 3.18 trillion by 2025 registering a CAGR of 10.6% over the forecast period, according to a new report by Grand View Research, Inc. Growing number of approved companion diagnostics and biomarker products have been proved promising avenues for the development of advanced precision diagnostic tests. Several personalized diagnostics and therapeutic products based on companion diagnostics are under clinical trials and development pipelines, which also add an incremental opportunity to accelerate this market.

Gene therapies are widely utilized to diagnose both chronic and genetic disorders according to individual's genetic makeup. Growing adoption of gene sequencing and data analytics technologies is anticipated to escalate precision medicine market growth. Decreasing cost of whole genome sequencing, advancement in cell biology sector, and the development of "Human Genome Project" are several other factors influencing the demand for gene therapy hence, boosting the overall market. Moreover, key leaders are undergoing numerous strategic developments to launch novel personalized products, which will also contribute to the market expansion.

For instance, in September 2018, Vertex Pharmaceuticals collaborated with Genomics for the delivery of precision medicine based on individual's genetic differences and lifestyle. Similarly, in January 2018, Foundation Medicine collaborated with European Organization for Research and Treatment of Cancer (EORTC) to facilitate Foundation's comprehensive genomic profiling to across personalized medicine and clinical trial enrolment.

Further key findings from the study suggest:

  • PM therapeutics is projected to register the fastest CAGR over the forecast period owing to the development of high-capacity rapid sequencing platforms for medical therapies
  • Reduction in sequencing cost leads to an expected growth of genomic sequencing and genetic research, thus contributing to lucrative opportunities for genomic medicine
  • Asia Pacific is projected to be the fastest-growing regional market due to rising number of collaborative initiatives between eastern and western market leaders
  • Chinese personalized medicine market is benefitted due to initiatives implemented by the Chinese government and reimbursements for disease treatment

Prominent companies include: GE Healthcare; Illumina, Inc.; Asuragen, Inc.; Abbott Laboratories; Dako A/S; Exact Science Corp.; and Biogen, Inc.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Market Segmentation & Scope
  • 1.2 Market Definition
  • 1.3 Information Procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources & third party perspectives
    • 1.3.4 Primary research
  • 1.4 Information Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Data Visualization
  • 1.6 Data Validation & Publishing

Chapter 2 Executive Summary

  • 2.1 Personalized Medicine Market Outlook, 2014 - 2025
  • 2.2 Personalized Medicine Market : Segment Outlook, 2014 - 2025
  • 2.3 Personalized Medicine Market : Competitive Insights

Chapter 3 Personalized Medicine Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2 Penetration & Growth Prospect Mapping For PM Diagnostics & PM Therapeutics, 2018
  • 3.3 Penetration &Growth Prospect Mapping For PM Medical Care & PM Nutrition, 2018
  • 3.4 Product Pipeline Analysis, by Stage
  • 3.5 Cost Structure Analysis
  • 3.6 User Perspective Analysis
    • 3.6.1. Consumer behavior analysis
    • 3.6.2. Market influencer analysis
  • 3.7 List of Key End-users By Region, By Test Type, By Application, By Country
  • 3.8 Technology Overview
    • 3.8.1. Technology timeline
  • 3.9 Regulatory Framework
    • 3.9.1. Reimbursement framework
    • 3.9.2. Standards & compliances
  • 3.10 Personalized Medicine Market - Market Dynamics
    • 3.10.1 Market driver analysis
      • 3.10.1.1 Advancement of next generation sequencing
      • 3.10.1.2 Growing number of companion/associated diagnostics
      • 3.10.1.3 Increasing number of retail clinics across the developed regions of North America and Europe
      • 3.10.1.4 Increasing prevalence of cancer
      • 3.10.1.5 Increasing prevalence of cancer is one of the key factors attributing
      • 3.10.1.6 Increasing usage of biomarkers for PM cancer therapy
    • 3.10.2 Market restraint analysis
      • 3.10.2.1 Presence of non-value-based PM diagnostics reimbursement policy
      • 3.10.2.2 Lack of proper intellectual property regulations for personalized medical technologies
      • 3.10.2.3 Non-structural development of biomarkers
    • 3.10.3 Market challenges analysis
      • 3.10.3.1 Burden of proof is greater for clinical validation for PM therapeutics
  • 3.11 Personalized Medicine Market Analysis Tools
    • 3.11.1 Industry Analysis - Porter's
      • 3.11.1.1 Supplier power : Low bargaining supplier power due to low complex nature of personalized medicines
      • 3.11.1.2 Buyer power: Moderate bargaining power of buyer as a result of low number of FDA approved products
      • 3.11.1.3 Substitution threat: Highly specific precision medicines leads to low threat of substitution
      • 3.11.1.4 New entrants threat: High initial investment results in moderate new entrant threat
      • 3.11.1.5 Competitive rivalry: Launch of novel personalized medicines leads to intense competition
    • 3.11.2 PESTEL analysis
      • 3.11.2.1 Political landscape
      • 3.11.2.2 Environmental landscape
      • 3.11.2.3 Social landscape
      • 3.11.2.4 Technology landscape
      • 3.11.2.5 Legal landscape
    • 3.11.3 Major deals & strategic alliances analysis
      • 3.11.3.1 Joint ventures
      • 3.11.3.2 Mergers & acquisitions
      • 3.11.3.3 Licensing & partnership
      • 3.11.3.4 Technology collaborations
      • 3.11.3.5 Strategic divestments
    • 3.11.4 Market entry strategies
    • 3.11.5 Case studies
  • 3.12 Personalized Medicine - Application Growth Prospects Analysis
    • 3.12.1 Personalized Medicine - Application Opportunity v/s Implementation
    • 3.12.2 Personalized Medicine - Application Opportunities Prioritized

Chapter 4 Personalized Medicine Market: Competitive Analysis

  • 4.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 4.2 Company/Competition Categorization
  • 4.3 Vendor Landscape
    • 4.3.1 List of key distributors and channel partners
    • 4.3.2 Key customers
    • 4.3.3 Key company market share analysis/ranking, 2018
  • 4.4 Public Companies
    • 4.4.1 Company market position analysis
    • 4.4.2 Company market share/ranking by region
    • 4.4.3 Competitive dashboard analysis
    • 4.4.4 Market differentiators
    • 4.4.5 Synergy analysis: Major deals & strategic alliances
  • 4.5 Private Companies
    • 4.5.1 List of key emerging companies
    • 4.5.2 Funding outlook
    • 4.5.3 Regional network map
    • 4.5.4 Company market position analysis
    • 4.5.5 List of Supplier

Chapter 5 Personalized Medicine Market Categorization: Product Estimates & Trend Analysis

  • 5.1 Definitions & Scope
  • 5.2 Product Market Share Analysis, 2018 & 2025
  • 5.3 Personalized Medicine Market: Product Movement Analysis, 2018 & 2025
  • 5.4 Global Personalized Medicine Market, by Product, 2014 to 2025
  • 5.5 Market Size & Forecasts and Trend Analyses, 2014 to 2025 for the following,
    • 5.5.1 PM diagnostics
      • 5.5.1.1 Global PM diagnostics market, 2014 - 2025 (USD Billion)
      • 5.5.1.2 Genetic testing
      • 5.5.1.2.1 Global genetic testing market, 2014 - 2025 (USD Billion)
      • 5.5.1.3 Direct-to-consumer (DTC) diagnostics
      • 5.5.1.3.1 Global DTC diagnostics market, 2014 - 2025 (USD Billion)
      • 5.5.1.4 Esoteric lab services
      • 5.5.1.4.1 Global esoteric lab services market, 2014 - 2025 (USD Billion)
      • 5.5.1.5 Esoteric lab tests
      • 5.5.1.5.1 Global esoteric lab tests market, 2014 - 2025 (USD Billion)
    • 5.5.2 PM therapeutics
      • 5.5.2.1 Global PM therapeutics market, 2014 - 2025 (USD Billion)
      • 5.5.2.2 Pharmaceuticals
      • 5.5.2.2.1 Global PM pharmaceuticals market, 2014 - 2025 (USD Billion)
      • 5.5.2.3 Genomic medicine
      • 5.5.2.3.1 Global genomic medicine market, 2014 - 2025 (USD Billion)
      • 5.5.2.4 Medical devices
      • 5.5.2.4.1 Global medical devices market, 2014 - 2025 (USD Billion)
    • 5.5.3 Personalized medical care
      • 5.5.3.1 Global personalized medical care market, 2014 - 2025 (USD Billion)
      • 5.5.3.2 Telemedicine
      • 5.5.3.2.1 Global telemedicine market, 2014 - 2025 (USD Billion)
      • 5.5.3.3 Health information technology
      • 5.5.3.3.1 Global health information technology market, 2014 - 2025 (USD Billion)
      • 5.5.3.4 Disease management
      • 5.5.3.4.1 Global disease management market, 2014 - 2025 (USD Billion)
    • 5.5.4 Personalized nutrition & wellness
      • 5.5.4.1 Global personalized nutrition & wellness market, 2014 - 2025 (USD Billion)
      • 5.5.4.2 Retail nutrition
      • 5.5.4.2.1 Global retail nutrition market, 2014 - 2025 (USD Billion)
      • 5.5.4.3 Complementary medicine
      • 5.5.4.3.1 Global complementary medicine market, 2014 - 2025 (USD Billion)
      • 5.5.4.4 Alternative medicine
      • 5.5.4.4.1 Global alternative medicine market, 2014 - 2025 (USD Billion)

Chapter 6 Personalized Medicine Market Categorization: Regional Estimates & Trend Analysis, by Product

  • 6.1 Personalized Medicine Market Share By Region, 2018 & 2025
  • 6.2 Regional Market Share and Leading Players, 2018
    • 6.2.1 North America
    • 6.2.2 Europe
    • 6.2.3 Asia Pacific
    • 6.2.4 Latin America
    • 6.2.5 Middle East & Africa
  • 6.3 North America
    • 6.3.1 North America personalized medicine market, 2014 - 2025 (USD Billion)
    • 6.3.2 U.S.
      • 6.3.2.1 U.S. personalized medicine market, 2014 - 2025 (USD Billion)
    • 6.3.3 Canada
      • 6.3.3.1 Canada personalized medicine market, 2014 - 2025 (USD Billion)
  • 6.4 Europe
    • 6.4.1 Europe personalized medicine market, 2014 - 2025 (USD Billion)
    • 6.4.2 Germany
      • 6.4.2.1 Germany personalized medicine market, 2014 - 2025 (USD Billion)
    • 6.4.3 U.K.
      • 6.4.3.1 U.K. personalized medicine market, 2014 - 2025 (USD Billion)
  • 6.5 Asia Pacific
    • 6.5.1 Asia Pacific personalized medicine market, 2014 - 2025 (USD Billion)
    • 6.5.2 Japan
      • 6.5.2.1 Japan personalized medicine market, 2014 - 2025 (USD Billion)
    • 6.5.3 China
      • 6.5.3.1 China personalized medicine market, 2014 - 2025 (USD Billion)
  • 6.6 Latin America
    • 6.6.1 Latin America personalized medicine market, 2014-2025 (USD Billion)
    • 6.6.2 Brazil
      • 6.6.2.1 Brazil personalized medicine market, 2014 - 2025 (USD Billion)
  • 6.7 Middle East & Africa (MEA)
    • 6.7.1 Middle East & Africa personalized medicine market, 2014 - 2025 (USD Billion)
    • 6.7.2 South Africa
      • 6.7.2.1 South Africa personalized medicine market, 2014 - 2025 (USD Billion)

Chapter 7 Competitive Landscape

  • 7.1 List of Companies
  • 7.2 Strategy Framework
  • 7.3 Market Participation Categorization
  • 7.4 Company Profiles
    • 7.4.1 Illumina Inc.
      • 7.4.1.1 Company Overview
      • 7.4.1.1 Financial Performance
      • 7.4.1.2 Product Benchmarking
      • 7.4.1.3 Strategic Initiatives
    • 7.4.2 GE Healthcare
      • 7.4.2.1 Company Overview
      • 7.4.2.2 Financial performance
      • 7.4.2.3 Product Benchmarking
      • 7.4.2.4 Strategic initiatives
    • 7.4.3 Asuragen Incorporated
      • 7.4.3.1 Company overview
      • 7.4.3.2 Financial performance
      • 7.4.3.3 Product Benchmarking
      • 7.4.3.4 Strategic Initiatives
    • 7.4.4 Cepheid
      • 7.4.4.1 Company Overview
      • 7.4.4.2 Financial Performance
      • 7.4.4.3 Product Benchmarking
      • 7.4.4.4 Strategic Initiatives
    • 7.4.5 Abbott Laboratories
      • 7.4.5.1 Company overview
      • 7.4.5.2 Financial performance
      • 7.4.5.3 Product Benchmarking
      • 7.4.5.4 Strategic Initiatives
    • 7.4.6 Dako A/S
      • 7.4.6.1 Company overview
      • 7.4.6.2 Financial performance
      • 7.4.6.3 Product Benchmarking
      • 7.4.6.4 Strategic Initiatives
    • 7.4.7 Exact Science Corporation
      • 7.4.7.1 Company Overview
      • 7.4.7.2 Financial Performance
      • 7.4.7.3 Product Benchmarking
      • 7.4.7.4 Strategic Initiatives
    • 7.4.8 Biogen
      • 7.4.8.1 Company Overview
      • 7.4.8.2 Financial Performance
      • 7.4.8.3 Product Benchmarking
      • 7.4.8.4 Strategic Initiatives
    • 7.4.9 Decode Genetics Inc
      • 7.4.9.1 Company Overview
      • 7.4.9.2 Financial Performance
      • 7.4.9.3 Product Benchmarking
      • 7.4.9.4 Strategic Initiatives
    • 7.4.10 Exagen Diagnostics Inc
      • 7.4.10.1 Company Overview
      • 7.4.10.2 Financial performance
      • 7.4.10.3 Product Benchmarking
      • 7.4.10.4 Strategic Initiatives
    • 7.4.11 Genelex Corporation
      • 7.4.11.1 Company Overview
      • 7.4.11.2 Financial Performance
      • 7.4.11.3 Product Benchmarking
      • 7.4.11.4 Strategic Initiatives
    • 7.4.12 Precision Biologics Incorporated
      • 7.4.12.1 Company Overview
      • 7.4.12.2 Financial Performance
      • 7.4.12.3 Product Benchmarking
      • 7.4.12.4 Strategic Initiatives
    • 7.4.13 QIAGEN
      • 7.4.13.1 Company Overview
      • 7.4.13.2 Financial Performance
      • 7.4.13.3 Product Benchmarking
      • 7.4.13.4 Strategic Initiatives
    • 7.4.14 Celera Diagnostics LLC
      • 7.4.14.1 Company overview
      • 7.4.14.2 Financial performance
      • 7.4.14.3 Product Benchmarking
      • 7.4.14.4 Strategic Initiatives
    • 7.4.15 Affymetrix Incorporated
      • 7.4.15.1 Company overview
      • 7.4.15.2 Financial performance
      • 7.4.15.3 Product Benchmarking
      • 7.4.15.4 Strategic Initiatives
    • 7.4.16 eviCore Healthcare (DNADirect Inc.)
      • 7.4.16.1 Company overview
      • 7.4.16.2 Financial performance
      • 7.4.16.3 Product Benchmarking
      • 7.4.16.4 Strategic Initiatives
    • 7.4.17 Agendia N.V.
      • 7.4.17.1 Company overview
      • 7.4.17.2 Financial performance
      • 7.4.17.3 Product Benchmarking
      • 7.4.17.4 Strategic Initiatives
Back to Top